Methylprednisolone Acetate
규격
53-36-1CAS 번호
200-171-3EC 번호
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetateIUPAC 명칭
C24H32O6화학식
416.5 g/mol분자량
Methylprednisolone acetate; 53-36-1; Depo-medrol; Depo-Medrate; M-Predrol; Medrol acetate; Depo-Medrone; Methylprednisolone 21-acetate; 6alpha-Methylprednisolone acetate; D-Med; 6alpha-Methylprednisolone 21-acetate; Depo-Methylprednisolone acetate; DTXSID7023302; Methyl prednisolone acetate; 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate; NSC-48985; 43502P7F0P; CHEBI:6889; DTXCID703302; NSC48985; (6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate; Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-; acetyl-methylprednisolone; Depo Medrone; Depo Medrol; methylprednisolone-21-acetate; Acetyl Methylprednisolone; Hybrisil; Methylprednisolone 21 acetate; Neo-medrone; Medroloan SUIK; Medroloan II SUIK; RefChem:55617; Methylprednisolone Acetate Inj.; ReadySharp MethylPrednisolone 80; 200-171-3; Medrol Enpak; Mepred; Urbason crystal suspension; Depomedrone; depMedalone 40; depMedalone 80; U 8210; 6?-Methyl Prednisolone 21-Acetate; MFCD00200356; [2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate; NSC 48985; Depo-methylprednisolone; Depometicort; Unidrol; Depo-Medrin; Lemod Depo; (6alpha,11beta)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione; Solsolona [inj.]; Ubrason [inj.]; Depot-Medrol; Solsolona; Ubrason; 2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate; Methylprednisolone EP Impurity J; MLS002667229; EINECS 200-171-3; 6-METHYLPREDNISOLONE ACETATE; 6.alpha.-Methylprednisolone acetate; Depo-medrate;; UNII-43502P7F0P; 6.alpha.-Methylprednisolone 21-acetate; NCGC00159503-02; Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-; Depo-medrol (TN); 6|A-Methyl Prednisolone 21-Acetate; Methylprednisolone acetate [USP:JAN]; 6alpha-Methyl Prednisolone 21-Acetate; component of Neo-Medrol; Methylprednisolon-21-acetat; Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6-alpha,11-beta)-; SCHEMBL13231; MLS001304003; Methylprednisolone acetate CRS; methyl prednisolone 21-acetate; CHEMBL1364144; MSK2257; BDBM233194; GLXC-23446; HMS2233N14; HMS3259L07; 6|A-Methylprednisolone 21-Acetate; Tox21_111722; HY-13681R; Methylprednisolone acetate (Standard); MSK2257-100A; s5973; Methylprednisolone acetate (JAN/USP); AKOS015969745; MSK2257-1000A; FM25549; NC00628; CAS-53-36-1; METHYLPREDNISOLONE ACETATE [JAN]; Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate; [2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate; HY-13681; METHYLPREDNISOLONE ACETATE [MART.]; METHYLPREDNISOLONE ACETATE [VANDF]; SMR000718757; SY067307; METHYLPREDNISOLONE ACETATE [USP-RS]; METHYLPREDNISOLONE ACETATE [WHO-DD]; CS-0007549; M2635; NS00014368; C08179; D00979; D87728; METHYLPREDNISOLONE ACETATE [GREEN BOOK]; METHYLPREDNISOLONE ACETATE [ORANGE BOOK]; AB00375925-05; METHYLPREDNISOLONE ACETATE [EP MONOGRAPH]; METHYLPREDNISOLONE ACETATE [USP IMPURITY]; F813564; METHYLPREDNISOLONE ACETATE [USP MONOGRAPH]; METHYLPREDNISOLONE IMPURITY J [EP IMPURITY]; Methylprednisolone acetate for system suitability CRS; Methylprednisolone acetate for peak identification CRS; Q27107351; NEO-MEDROL ACETATE COMPONENT METHYLPREDNISOLONE ACETATE; Methylprednisolone 21-acetate Solution in Acetonitrile, 1000ug/mL; Methylprednisolone 21-acetate Solution in Acetonitrile, 100ug/mL; 21-Acetoxy-11?,17-dihydroxy-6?-methylpregna-1,4-diene-3,20-dione; METHYLPREDNISOLONE HYDROGEN SUCCINATE IMPURITY C [EP IMPURITY]; (6|A,11|A)-21-(Acetyloxy)-11,17-dihydroxy-6-Methylpregna-1,4-diene-3,20-dione; 11beta,17-Dihydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate; Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate; Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-; Methylprednisolone EP Impurity J; Methylprednisolone Acetate; Methylprednisolone Hydrogen Succinate EP Impurity C동의어
Methylprednisolone Acetate 함유 제품
류마론주사(초산메칠프레드니솔론)(수출용)(수출명: CBIPRED Inj.)デポ・メドロール水懸注40mgデポ・メドロール水懸注20mgDEPO-MEDROL 40 mg/1 mL, suspension injectable en flaconDepo-medrolDepocortinDepo-MedrolMethylprednisolone Acetate - Fagron GroupMethylprednisolone Acetate - Henan Lihua PharmaceuticalMethylprednisolone Acetate - Zhejiang Xianju Pharmaceutical Co. LtdMethylprednisolone Acetate - Hikma PharmaceuticalsMethylprednisolone Acetate - Anuh Pharma
1/2 페이지
Methylprednisolone Acetate 판매 기업
AD
ACS DOBFAR SPAItalyZX
Zhejiang Xianju Pharmaceutical Co. LtdChinaZS
Zhejiang Shenzhou Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChina1/2 페이지